Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0000950170-25-098788
Filing Date
2025-07-25
Accepted
2025-07-25 16:15:39
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-1 apvo-2025-s1_-_eloc.htm S-1 1075000
2 EX-5.1 apvo-ex5_1.htm EX-5.1 30427
3 EX-23.1 apvo-ex23_1.htm EX-23.1 4872
4 EX-FILING FEES apvo-exfiling_fees.htm EX-FILING FEES 72946
5 GRAPHIC img13746759_0.jpg GRAPHIC 6733
6 GRAPHIC img13746759_1.jpg GRAPHIC 14823
7 GRAPHIC img57496738_0.jpg GRAPHIC 12962
  Complete submission text file 0000950170-25-098788.txt   1232240
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-288959 | Film No.: 251151868
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)